Fundraising FoxWONIK Investment Partners — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Korean immuno-oncology biotech developing multi-specific antibody and immune-cytokine fusion therapies for cancer.
Co-investorsAtinum Investment Co. Ltd.Premier PartnersKorea Development BankKorea Investment PartnersShinhan Capital
XCENA develops computational memory hardware that combines high-capacity pooled DDR5 memory with near-data processing (NDP) cores, built on the open Compute Express Link (CXL) standard to expand memory beyond CPU limits and run computation where data resides.
AI & Machine LearningDeep TechHardwareSemiconductors
Jin Kim(Founder)inDoHun Kim(Founder)Harry Juhyun Kim(Founder)
Co-investorsAtinum Investment Co. Ltd.Kiwoom InvestmentCompany K PartnersDSC InvestmentIMM InvestmentKDB Capital+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.